Silent Myocardial Ischemia: A Clinical Perspective

Archives of Internal Medicine

Volumn 151, Issue 12, 1991, Pages 2373-2382

  Deedwania, Prakash C ^a,b   Carbajal, Enrique V ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; METOPROLOL; NIFEDIPINE;

ADULT; ANGINA PECTORIS; CORONARY ARTERY DISEASE; DRUG EFFICACY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MYOCARDIAL DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

CIRCADIAN RHYTHM; CORONARY DISEASE; HUMAN; PREVALENCE; PROGNOSIS;

EID: 0026321071     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1991.00400120019004     Document Type: Article

References (104)

1. Kannel WB, Abbot RD. Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham study. N Engl J Med. 1984;311:1144-1147.
2. Deedwania P. Silent myocardial ischemia and its relationship to acute myocardial infarction. Cardiol Clin. 1986;4:643-658.
3. Cohn P. Silent myocardial ischemia: dimensions of the problem in patients with and without angina. Am J Med. 1986;80(suppl 4C):3-8.
4. Reeves T. Relation and independence of angina pectoris and sudden death in persons with coronary atherosclerotic heart disease. J Am Coll Cardiol. 1985;5:167B-174B.
5. Cohn PF, Harris P, Barry WH, Rosati RA, Rosenbaum P, Waternaux C. Prognostic importance of anginal symptoms in angiographically defined coronary artery disease. Am J Cardiol. 1981;47:233-237.
6. Hultgren H, Peduzzi P. Participants of the Veterans Administration cooperative study of surgery for coronary arterial occlusive disease: relation of severity of symptoms to prognosis in stable angina pectoris. Am J Cardiol. 1984;54:988-993.
7. Stern S, Tzivoni D, Stern Z. Diagnostic accuracy of ambulatory ECG monitoring in ischemic heart disease. Circulation. 1975;52:1045-1049.
8. Deanfield J, Shea M, Selwyn A. Clinical evaluation of transient myocardial ischemia during daily life. Am J Med. 1985;79(suppl 3A):18-24.
9. Schang S, Pepine C. Transient asymptomatic ST-segment depression during daily activity. Am J Cardiol. 1977;39:396-402.
10. Deanfield J, Shea M, Ribiero P, et al. Transient ST-segment depression as a marker of myocardial ischemia during daily life: a physiological validation in patients with angina and coronary disease. Am J Cardiol. 1984;54:1195-1200.
11. Cohn PF. Silent myocardial ischemia. Ann Intern Med. 1988;109:312-317.
12. Mulcahy D, Keegan J, Crean P, et al. Silent myocardial ischaemia in chronic stable angina: a study of its frequency and characteristics in 150 patients. Br Heart J. 1988;60:417-423.
13. Deedwania P, Carbajal E. Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy. Am J Cardiol. 1990;65:1090-1096.
14. Cohn P, Vetrovec G, Nesto R, Gerber F. The nifedipine-total ischemia awareness program: a national survey of painful and painless myocardial ischemia including results of antiischemic therapy. Am J Cardiol. 1989;63:534-539.
15. Deedwania P, Carbajal E. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation. 1990;81:748-756.
16. Rocco M, Nabel E, Campbell S, et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease. Circulation. 1988;78:877-884.
17. Gordon T, Kannel W. Premature mortality from coronary heart disease: the Framingham study. JAMA. 1971;215:1617-1625.
18. Warnes CA, Roberts WC. Sudden coronary death: relation of amount and distribution of coronary narrowing at necropsy to previous symptoms of myocardial ischemia, left ventricular scarring and heart weight. Am J Cardiol. 1984;54:6.
19. Kannel W. Prevalence and clinical aspects of unrecognized myocardial infarction and sudden unexpected death. Circulation. 1987;75(suppl 2):4-5.
20. Multiple Risk Factor Intervention Trial Research Group. Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Am J Cardiol. 1985;55:16-24.
21. Gordon D, Ekelund L, Karon J, et al. Predictive value of the exercise tolerance test for mortality in North American men: the lipid research clinics mortality follow-up study. Circulation. 1986;74:252-261.
22. Giagnoni E, Secchi MB, Wu SC, et al. Prognostic value of exercise EKG testing in asymptomatic normotensive subjects: a prospective matched study. N Engl J Med. 1983;309:1085-1089.
23. Erikssen J, Thaulow E. Follow-up of patients with asymptomatic myocardial ischemia. In: Rutishauser W, Roskamm H, eds. Silent Myocardial Ischemia. Berlin, Germany: Springer-Verlag; 1984:156-164.
24. Froelicher V, Yanowitz F, Thompson A, Lancaster MC. The correlation of coronary angiography and the electrocardiographic response to maximal treadmill testing in 76 asymptomatic men. Circulation. 1973;48:597-604.
25. Langou R, Huang E, Kelley M, Cohen LS. Predictive accuracy of coronary artery calcification and abnormal exercise test for coronary artery disease in asymptomatic men. Circulation. 1980;62:1196-1203.
26. Parmley W. Prevalence and clinical significance of myocardial ischemia. Circulation. 1989;80(suppl 4):68-73.
27. Holter N. New method for heart studies: continuous electrocardiography of active subjects over long periods is now practical. Science. 1961;134:1214-1220.
28. Goldhammer S, Scherf D. Elektrokardiographische Untersuchungen bei Kranken mit Angina Pectoris. Z Klin Med. 1932;122:134-151.
29. Pepine C. Silent myocardial ischemia: definition, magnitude, and scope of the problem. Cardiol Clin. 1986;4:577-581.
30. Pepine C. Ambulant myocardial ischemia and its prognostic implications. Circulation. 1990;81:1136-1138.
31. Sigwart U, Grbic M, Payot M, et al. Ischemic events during coronary artery balloon obstruction. In: Rutishauser W, Roskamm H, eds. Silent Myocardial Ischemia. Berlin, Germany: Springer-Verlag; 1984:29-36.
32. Nabel E, Rocco M, Barry J, Campbell S, Selwyn A. Asymptomatic ischemia in patients with coronary artery disease. JAMA. 1987;257:1923-1928.
33. Epstein S, Quyyumi A, Bonow R. Myocardial ischemia: silent or symptomatic. N Engl J Med. 1988;318:1038-1043.
34. Droste C, Roskamm H. Experimental pain measurement in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol. 1983;1:940-945.
35. Pedersen F, Pietersen A, Madsen J, Ballegaard S, Meyer C, Trojaborg W. Elevated pain threshold in patients with effort-induced angina pectoris and asymptomatic myocardial ischemia during exercise test. Clin Cardiol. 1989;12:639-642.
36. Glazier JJ, Chierchia S, Brown MJ, Maseri A. Importance of generalized defective perception of painful stimuli as a cause of silent myocardial ischemia in chronic stable angina pectoris. Am J Cardiol. 1986;58:667-672.
37. Sheps D, Adams K, Hinderliter A, et al. Endorphins are related to pain perception in coronary artery disease. Am J Cardiol. 1987;59:523-527.
38. Perna G, Stanislao M, Salvatori M, et al. Basal plasma beta-endorphin and beta-lipotropin in patients with symptomatic and asymptomatic myocardial ischemia. Cardiologia. 1988;33:765.
39. Cohn P. Silent myocardial ischemia in patients with a defective anginal warning system. Am J Cardiol. 1980;45:697-702.
40. Furchgott R, Vanhoutte P. Endothelium-derived relaxing and contracting factors. FASEB J. 1989;3:2007-2018.
41. Deanfield J, Maseri A, Selwyn A, et al. Myocardial ischemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet. 1983;2:753-758.
42. Chierchia S, Gallino A, Smith G, et al. Role of heart rate in pathophysiology of chronic stable angina. Lancet. 1984;2:1353-1357.
43. Quyyumi AA, Wright CA, Mockus LJ, Fox KM. Mechanisms of nocturnal angina pectoris: importance of increased myocardial oxygen demand in patients with severe coronary artery disease. Lancet. 1984;1:1207-1209.
44. Hausmann D, Nikutta P, Daniel W, Lichtlen P. Increase in heart rate as the predominant trigger of symptomatic and silent myocardial ischemia in patients with angina pectoris. Circulation. 1987;76(suppl 4):IV-391. Abstract.
45. Deedwania P, Nelson J. Pathophysiology of silent myocardial ischemia during daily life: hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. Circulation. 1990;82:1296-1304.
46. Rocco M, Barry J, Campbell S, et al. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation. 1987;75:395-400.
47. Muller J, Stone P, Turi Z, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 1985;313:1315-1322.
48. Muller J, Ludmer P, Willich S, et al. Circadian variation in the frequency of sudden cardiac death. Circulation. 1987;75:131-138.
49. Willich S, Levy D, Rocco M, Tofler H, Stone P, Muller J. Circadian variation in the incidence of sudden cardiac death in the Framingham heart study population. Am J Cardiol. 1987;60:801-806.
50. Quyyumi AA, Mockus L, Wright C, Fox K. Morphology of ambulatory ST segment changes in patients with varying severity of coronary artery disease: investigation of the frequency of nocturnal ischaemia and coronary spasm. Br Heart J. 1985;53:186-193.
51. Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S. Circadian variation of exercise capacity in patients with Prinzmetal’s variant angina: role of exercise induced coronary arterial spasm. Circulation. 1979;59:938-948.
52. Miller-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood pressure. Lancet. 1978;1:795-797.
53. Folts J, Crowell E, Rowe G. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation. 1976;54:365-370.
54. Tofler GH, Brezinski D, Schafer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med. 1987;316:1514-1518.
55. Rosing DR, Brakman P, Redwood DR, et al. Blood fibrinolytic activity in man: diurnal variation and the response to varying intensities of exercise. Circ Res. 1970;27:171-184.
56. Ellestad M. Stress Testing: Principles and Practice. 3rd ed. Philadelphia, Pa: FA Davis; 1986.
57. Bruce R, McDonough J. Stress testing in screening for cardiovascular disease. Bull N Y Acad Med. 1969;45:1288-1305.
58. Goldschlager N, Selzer A, Cohn K. Treadmill stress tests as indicators of presence and severity of coronary artery disease. Ann Intern Med. 1976;85:277-286.
59. Callaham PR, Froelicher VF, Klein J, Risch M, Dubach P, Friis R. Exercise-induced silent ischemia: age, diabetes mellitus, previous myocardial infarction and prognosis. J Am Coll Cardiol. 1989;14:1175-1180.
60. Botvinick E, Shames D, Gershengorn K. The clinical advantages of myocardial perfusion scintigraphy with rubidium-81 over stress electrocardiography. Am J Cardiol. 1977;39:364-371.
61. Berger B, Chung E. Myocardial perfusion imaging with thallium-201: principles and clinical applications. In: Chung E, ed. Exercise Electrocardiography: A Practical Approach. Baltimore, Md: Williams & Wilkins; 1985:291-312.
62. Cohn PF, Brown EJ Jr, Wynne J, Holman BL, Atkins HL. Global and regional left ventricular ejection fraction abnormalities during exercise in patients with silent myocardial ischemia. J Am Coll Cardiol. 1983;1:931-933.
63. Singh B, Nademanee K, Figueras J, Josephson M. Hemodynamic and electrocardiographic correlates of symptomatic and silent myocardial ischemia: pathophysiologic and therapeutic implications. Am J Cardiol. 1986;58:3B-10B.
64. Balasubramanian V. Clinical and research applications of ambulatory Holter ST-segment and heart rate monitoring. Am J Cardiol. 1986;58:11B-20B.
65. Deanfield J. Holter monitoring in assessment of angina pectoris. Am J Cardiol. 1987;59:18C-22C.
66. Cohn P, Kannel W. Recognition, pathogenesis, and management options in silent coronary artery disease: summary. Circulation. 1987;75(suppl 2):54.
67. Selwyn A, Allen R, L’Abbate L, et al. Relationship between regional myocardial uptake of rubidium-82 and perfusion: absolute reduction of cation uptake in ischemia. Am J Cardiol. 1982;50:112-121.
68. Levy R, Shapiro LM, Wright C, Mockus L, Fox K. The haemodynamic significance of asymptomatic ST segment depression assessed by ambulatory pulmonary artery pressure monitoring. Br Heart J. 1986;56:526-530.
69. Hirzel H, Leutwyler R, Krayenbuehl H. Silent myocardial ischemia: hemodynamic changes during dynamic exercise in patients with proven coronary artery disease despite absence of angina pectoris. J Am Coll Cardiol. 1985;6:275-284.
70. Berman D, Rozanski A, Knoebel S. The detection of silent ischemia: cautions and precautions. Circulation. 1987;75:101-105.
71. Tzivoni D, Stern Z, Keren A, Stern S. Electrocardiographic characteristics of neurocirculatory asthenia during everyday activities. Br Heart J. 1980;44:426-432.
72. Stern S, Tzivoni D. Dynamic changes in the ST-T segment during sleep in ischemic heart disease. Am J Cardiol. 1973;32:17-20.
73. Deanfield J, Ribiero P, Oakley K, Krikler S, Selwyn AP. Analysis of ST-segment changes in normal subjects: implications for ambulatory monitoring in angina pectoris. Am J Cardiol. 1984;54:1321-1325.
74. Deedwania P, Carbajal E. Ambulatory ECG recordings for myocardial ischemia: methodology, definitions, pathophysiology, prevalence, and prognostic importance. J Myocard Ischemia. 1991. In press.
75. Sharma B, Asinger R, Francis G. Demonstration of exercise-induced painless myocardial ischemia in survivors of out-of-hospital ventricular fibrillation. Am J Cardiol. 1987;59:740-745.
76. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979;300:1350-1358.
77. Theroux P, Waters DD, Halphen C, Debaisieux JC, Mizgala HF. Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med. 1979;301:341-345.
78. Gottlieb SO, Gottlieb SH, Achuff SC, et al. Silent ischemia on Holter monitoring predicts mortality in high-risk postinfarction patients. JAMA. 1988;259:1030-1035.
79. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med. 1986;314:1214-1219.
80. Nademanee K, Intarachot V, Josephson MA, et al. Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol. 1987;1:1-9.
81. Bonow R, Bacharach S, Green M, LaFreniere R, Epstein S. Prognostic implications of symptomatic versus asymptomatic (silent) myocardial ischemia induced by exercise in mildly symptomatic and in asymptomatic patients with angiographically documented coronary artery disease. Am J Cardiol. 1987;60:778-783.
82. Weiner D, Ryan T, McCabe C, Ng G, et al. Risk of developing an acute myocardial infarction or sudden coronary death in patients with exercise-induced silent myocardial ischemia: a report from the Coronary Artery Surgery Study (CASS) Registry. Am J Cardiol. 1988;62:1155-1161.
83. Rozanski A, Berman D. Silent myocardial ischemia, I: pathophysiology, frequency of occurrence, and approaches toward detection. Am Heart J. 1987;114:615-626.
84. Erikssen J, Thaulow E, Cohn P: Long-term prognosis of 50 totally asymptomatic middle-aged men with silent myocardial ischemia and angiographically documented coronary artery disease. Circulation 1987;76(suppl 4):77. Abstract.
85. Tzivoni D, Gavish A, Zin D, et al. Prognostic significance of ischemic episodes in patients with previous myocardial infarction. Am J Cardiol. 1988;62:661-664.
86. Johnson SM, Mauritson DR, Winniford MD, et al. Continuous electrocardiographic monitoring in patients with unstable angina pectoris: identification of high-risk subgroup with severe coronary disease, variant angina, and/or impaired early prognosis. Am Heart J. 1982;103:4-12.
87. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenglith G. Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina. J Am Coll Cardiol. 1987;10:756-760.
88. Pepine CJ. Is silent ischemia a treatable risk factor in patients with angina pectoris? Circulation. 1990;82(suppl 2): 135-142.
89. Geft I, Fischbein M, Ninomiya K. Intermittent brief periods of ischemia have a cumulative effect and may cause myocardial necrosis. Circulation. 1982;66:1150-1153.
90. Schaper J. Effects of multiple ischaemic events on human myocardium: an ultrastructural study. Eur Heart J. 1988;9(suppl A):141-149.
91. Hess O, Schneider J, Nonogi H, et al. Myocardial structure in patients with exercise-induced ischemia. Circulation. 1977;5:967-977.
92. Deedwania P, Carbajal E. Silent ischemia: prognosis and therapy. Cardio. 1989:53-60.
93. Imperi G, Lambert C, Coy K, Lopez L, Pepine C. Effects of titrated beta-blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery disease. Am J Cardiol. 1987;60:519-524.
94. Gonzalez J, Hill J, Kolb R, Franco E, Pepine C. Effects of atenolol and nifedipine alone and in combination on ambulant myocardial ischemia in minimally symptomatic patients. J Am Coll Cardiol. 1990;15:120. Abstract.
95. Mulcahy D, Keegan J, Cunningham D, et al. Circadian variation of total ischaemic burden and its alternation with anti-anginal agents. Lancet. 1988;2:755-759.
96. Deedwania PC, Carbajal EV, Nelson JR, Hait H. Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia. J Am Coll Cardiol. 1990;17:963-969.
97. Muller JE, Tofler GI, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79:733-743.
98. Deedwania P. Transient myocardial ischemia in survivors of acute myocardial infarction and angina. In: Singh BN, ed. Silent Myocardial Ischemia and Angina: Prevalence, Prognostic, and Therapeutic Significance. New York, NY: Pergamon Press; 1988:147-156.
99. Krone RJ, Gillespie JA, Weld FM, et al. Low level exercise testing after myocardial infarction: usefulness in enhancing clinical risk stratification. Circulation. 1985;71:80-89.
100. Waters DD, Bosch X, Bouchard A, et al. Comparison of clinical variables and variables derived from a limited predischarge exercise test as predictors of early and late mortality after myocardial infarction. Am J Coll Cardiol. 1985;5:1-8.
101. Jesperson CM, Kassis E, Edeling CJ, et al. The prognostic value of maximal exercise testing soon after first myocardial infarction. Eur Heart J. 1985;6:769-772.
102. Starling M, Crawford MH, Kennedy GT, et al. Exercise testing early after myocardial infarction: predictive value for subsequent unstable angina and death. Am J Cardiol. 1980;46:909-914.
103. Davidson DM, DeBusk R. Prognostic value of a single exercise test 3 weeks after uncomplicated myocardial infarction. Circulation. 1980;61:236-242.
104. Markiewicz W, Houston N, DeBusk R. Exercise testing soon after myocardial infarction. Circulation. 1977;56:26-31.